Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Ophthalmology

What Does Plus Disease Mean in Retinopathy of Prematurity?

At a Glance

Plus disease means the retinal blood vessels in a premature baby’s eye are unusually swollen and twisted, signaling severe, active retinopathy of prematurity. It does not by itself mean vision is already lost, but it often requires prompt specialist assessment and treatment.

Plus disease is a term eye doctors use when the blood vessels in the light-sensing layer of the eye (the retina) have become abnormally dilated (thick and swollen) and tortuous (twisted) [1] [2].

When a doctor diagnoses plus disease, it means the Retinopathy of Prematurity (ROP) is severe and active, carrying a high risk of progressing to vision-threatening disease [3] [4].

Hearing this terminology can be frightening, but it is important to know that plus disease does not mean your baby has already lost vision or has a retinal detachment. However, it is a major clinical warning sign that usually requires prompt assessment and management by an ROP specialist [5].

What Exactly Is Happening in the Eye?

In normal eye development, blood vessels grow smoothly from the optic nerve to the edges of the retina. In ROP, this growth is interrupted. When the condition becomes severe, the abnormal blood vessels undergo two distinct changes:

  • Venous dilation: The veins (vessels carrying blood back to the heart) become abnormally thick and swollen [2].
  • Arteriolar tortuosity: The arteries (vessels carrying oxygen-rich blood) become highly twisted, wavy, and crooked [1].

Doctors compare what they see in your baby’s eye against standard reference photographs to diagnose plus disease [1].

Because these vessel changes happen on a continuous spectrum, doctors sometimes use the term pre-plus disease [6]. Pre-plus means the blood vessels are beginning to look abnormal, but have not reached the severity of full plus disease [7]. Pre-plus is an early warning sign that the eyes require closer follow-up to monitor for progression [8].

How “Plus” Fits Into the Diagnosis

To fully understand how severe the ROP is, doctors assess three distinct factors for each eye:

  1. Zone: The location of the abnormal growth in the eye.
  2. Stage: How severe the abnormal tissue looks.
  3. Plus Status: Whether the eye has plus disease, pre-plus, or neither [6].

Plus disease is a key piece of the puzzle, but it is not the only factor that determines whether your baby needs treatment [9].

The Trigger for Prompt Treatment

Many mild cases of ROP heal completely on their own. However, the presence of plus disease significantly lowers the likelihood of spontaneous healing—one study found it resolved without treatment in only about 13% of cases [4]. If severe ROP is left untreated, the abnormal tissue can eventually contract and pull the retina away from the back of the eye (tractional retinal detachment), causing permanent vision loss [9].

Plus disease is a major factor in identifying Type 1 ROP, which is the specific threshold where medical guidelines recommend prompt treatment [10] [11]. A baby has Type 1 ROP if they meet any of these criteria:

  • ROP in Zone I at any stage, with plus disease
  • ROP in Zone I at Stage 3, without plus disease
  • ROP in Zone II at Stage 2 or 3, with plus disease

Notice that plus disease does not automatically make every case Type 1 ROP, and some cases qualify for treatment even without plus disease [10]. However, when plus is present in the critical zones, it typically acts as the tipping point for intervention [11].

Treatment Options and What to Expect

If your baby meets the criteria for treatment, the specialist will recommend a prompt intervention. While treatment significantly reduces the risk of severe structural damage and vision loss, it does not guarantee perfect vision [5]. The two main options are:

  • Laser therapy: Uses targeted light to stop the abnormal vessel growth.
  • Anti-VEGF injections: Medication injected into the eye to block the signals causing the abnormal growth (this may be an off-label use for premature infants, depending on the medication and jurisdiction) [12].

The specialist will recommend the best option based on the exact zone and stage of the disease, as well as your baby’s overall health [12].

Crucial Note on Follow-Up: Treatment does not end the ROP journey. Particularly after anti-VEGF injections, ROP can sometimes reactivate weeks or even months later [13]. Strict attendance at all follow-up appointments is absolutely essential to protect your baby’s vision, even if their eyes look perfectly fine from the outside [13]. Over the long term, children with treated ROP will also need ongoing ophthalmic monitoring for issues like the need for glasses, amblyopia (lazy eye), and strabismus (crossed eyes).

Common questions in this guide

How serious is a plus finding in my baby's ROP?
Plus disease means the retinal blood vessels are unusually swollen and twisted. It signals severe, active ROP and a higher risk of vision-threatening progression, so an ROP specialist should assess the baby promptly. It does not by itself prove that vision has been lost or that retinal detachment has occurred.
Does plus disease mean my baby has lost vision or has a detached retina?
No. Plus disease is a warning sign, not the same as retinal detachment or confirmed vision loss. Untreated severe ROP can pull the retina away from the back of the eye, which is why timely specialist care matters.
What is the difference between pre-plus and plus disease?
Pre-plus means the retinal vessels are starting to look abnormal but do not yet meet the full plus-disease threshold. It can progress, so doctors generally arrange closer monitoring. The distinction is made by comparing the eye examination with standard reference images.
How do doctors decide whether ROP with plus disease needs treatment?
Treatment decisions use the ROP zone and stage for each eye as well as plus status. Plus disease in certain zones and stages can meet Type 1 ROP criteria, for which guidelines recommend prompt treatment, while plus disease alone does not automatically make every case Type 1. The specialist also considers the baby's overall health.
What treatments can be used for ROP with plus disease?
The main options are laser therapy, which slows abnormal vessel growth, and an anti-VEGF medicine injected into the eye, which blocks growth signals. The best choice depends on the zone, stage, plus status, and the baby's health; some anti-VEGF use in premature infants may be off-label depending on the medication and jurisdiction.
Why are follow-up eye exams still needed after treatment?
Follow-up is essential because ROP can become active again weeks or months after treatment, particularly after an eye injection. Children treated for ROP also need longer-term eye checks for glasses, lazy eye, or crossed eyes. Keep every appointment even if the eyes look normal from the outside.

Get notified when new evidence is published on Retinopathy of prematurity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Plus Disease in Retinopathy of Prematurity: More Than Meets the ICROP?

    Ghergherehchi L, Kim SJ, Campbell JP, et al.

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(3)):152-155 doi:10.22608/APO.201863.

    PMID: 29797825
  2. 2

    Retinopathy of prematurity: from oxygen management to molecular manipulation.

    Woods J, Biswas S

    Molecular and cellular pediatrics 2023; (10(1)):12 doi:10.1186/s40348-023-00163-5.

    PMID: 37712996
  3. 3

    Persistent Plus Disease Subsequent to Panretinal Photocoagulation in an Infant With Retinopathy of Prematurity.

    Shah SM, Callaway NF, Moshfeghi DM

    Ophthalmic surgery, lasers & imaging retina 2019; (50(8)):520-521 doi:10.3928/23258160-20190806-08.

    PMID: 31415700
  4. 4

    Clinical feature and predictive factor analysis for spontaneous regression of retinopathy of prematurity in a Chinese population.

    Li YA, Zhou XH, Cai XJ, Yang CH

    International journal of ophthalmology 2022; (15(12)):1978-1984 doi:10.18240/ijo.2022.12.13.

    PMID: 36536972
  5. 5

    Screening Examination of Premature Infants for Retinopathy of Prematurity.

    Fierson WM, , , et al.

    Pediatrics 2018; (142(6)) doi:10.1542/peds.2018-3061.

    PMID: 30478242
  6. 6

    International Classification of Retinopathy of Prematurity, Third Edition.

    Chiang MF, Quinn GE, Fielder AR, et al.

    Ophthalmology 2021; (128(10)):e51-e68 doi:10.1016/j.ophtha.2021.05.031.

    PMID: 34247850
  7. 7

    P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity.

    Binenbaum G, Stahl A, Coyner AS, et al.

    Ophthalmology 2024; (131(11)):1297-1303 doi:10.1016/j.ophtha.2024.05.019.

    PMID: 38795976
  8. 8

    Progression from preplus to plus disease in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study: incidence, timing, and predictors.

    Cheng QE, Quinn GE, Daniel E, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2020; (24(6)):354.e1-354.e6 doi:10.1016/j.jaapos.2020.07.016.

    PMID: 33212296
  9. 9

    Computer-Assisted Digital Image Analysis of Plus Disease in Retinopathy of Prematurity.

    Kemp PS, VanderVeen DK

    Seminars in ophthalmology 2016; (31(1-2)):159-62 doi:10.3109/08820538.2015.1114859.

    PMID: 26959142
  10. 10

    Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity.

    Karkhaneh R, Torabi H, Khodabande A, et al.

    Journal of ophthalmic & vision research 2018; (13(1)):29-33 doi:10.4103/jovr.jovr_198_16.

    PMID: 29403586
  11. 11

    COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY.

    Zhang G, Yang M, Zeng J, et al.

    Retina (Philadelphia, Pa.) 2017; (37(4)):710-717 doi:10.1097/IAE.0000000000001241.

    PMID: 27529839
  12. 12

    Management of Retinopathy of Prematurity in the United Arab Emirates: A Consensus Statement From the Emirates Society of Ophthalmology.

    Al Ali AK, Al Qassimi N, Al Shamsi H, et al.

    Cureus 2026; (18(2)):e103096 doi:10.7759/cureus.103096.

    PMID: 41804441
  13. 13

    [Retinopathy of Prematurity - Update on Classification, Screening, and Therapy].

    Li JQ, Kellner U, Lorenz B, et al.

    Klinische Monatsblatter fur Augenheilkunde 2022; (239(3)):346-363 doi:10.1055/a-1758-3020.

    PMID: 35253129

This page explains plus disease in a premature baby's eyes for informational purposes only and does not replace medical advice. Your baby's ROP specialist should interpret the eye examination and recommend the appropriate timing and treatment.